IBDEI096 ; ; 18-FEB-2009
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 18, 2009
 Q:'DIFQR(358.4)  F I=3D1:2 S X=3D$T(Q+I) Q:X=3D""  S
Y=3D$E($T(Q+I+1),4,999),X=3D$E(X,4,999) S:$A(Y)=3D126
I=3DI+1,Y=3D$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=3D61 Y=3D$E(Y,2,999) =
X NO E
S @X=3DY
Q Q
 ;;^UTILITY(U,$J,358.4,411,0)
 ;;=3DHEADACHE^6^49
 ;;^UTILITY(U,$J,358.4,412,0)
 ;;=3DDIZZINESS^3^49
 ;;^UTILITY(U,$J,358.4,413,0)
 ;;=3DNEURODEGENERATIVE DIS^9^49
 ;;^UTILITY(U,$J,358.4,414,0)
 ;;=3DPAIN^12^49
 ;;^UTILITY(U,$J,358.4,415,0)
 ;;=3DNEUROPATHIES^10^49
 ;;^UTILITY(U,$J,358.4,416,0)
 ;;=3DENCEPALOPATHY^4^49
 ;;^UTILITY(U,$J,358.4,417,0)
 ;;=3DSPINAL CONDITIONS^14^49
 ;;^UTILITY(U,$J,358.4,418,0)
 ;;=3DVISION DISTURBANCES^16^49
 ;;^UTILITY(U,$J,358.4,419,0)
 ;;=3DMOVEMENT DISORDERS^15^49
 ;;^UTILITY(U,$J,358.4,420,0)
 ;;=3DOTHER^13^49
 ;;^UTILITY(U,$J,358.4,421,0)
 ;;=3DCARDIAC DISORDERS^1^49
 ;;^UTILITY(U,$J,358.4,422,0)
 ;;=3DNEOPLASMS^8^49
 ;;^UTILITY(U,$J,358.4,423,0)
 ;;=3DSYMPTOMS^17^49
 ;;^UTILITY(U,$J,358.4,424,0)
 ;;=3DANEMIA^1^50
 ;;^UTILITY(U,$J,358.4,425,0)
 ;;=3DCOAGULATION DISORDERS^2^50
 ;;^UTILITY(U,$J,358.4,426,0)
 ;;=3DMYELOID NEOPLASMS & DISORDERS^3^50
 ;;^UTILITY(U,$J,358.4,427,0)
 ;;=3DLYMPHOID NEOPLASMS^4^50
 ;;^UTILITY(U,$J,358.4,428,0)
 ;;=3DGI CANCER^5^50
 ;;^UTILITY(U,$J,358.4,429,0)
 ;;=3DHEAD, NECK & LUNG NEOPLASMS^6^50
 ;;^UTILITY(U,$J,358.4,430,0)
 ;;=3DMISC. NEOPLASMS^7^50
 ;;^UTILITY(U,$J,358.4,431,0)
 ;;=3DMETASTATIC SITES^8^50
 ;;^UTILITY(U,$J,358.4,432,0)
 ;;=3DCOUNSELING & SCREENING^9^50
 ;;^UTILITY(U,$J,358.4,433,0)
 ;;=3DHEMOGLOBINOPATHIES^1.5^50
 ;;^UTILITY(U,$J,358.4,434,0)
 ;;=3DGENITOURINARY NEOPLASMS^6.5^50
 ;;^UTILITY(U,$J,358.4,435,0)
 ;;=3DBREAST & GYN NEOPLASMS^6.75^50
 ;;^UTILITY(U,$J,358.4,436,0)
 ;;=3DARTIFICIAL OPENING STATUS^14^50
 ;;^UTILITY(U,$J,358.4,437,0)
 ;;=3DPERSONAL HX OF CANCER^15^50
 ;;^UTILITY(U,$J,358.4,438,0)
 ;;=3DSPECIAL SERVICES^5^51
 ;;^UTILITY(U,$J,358.4,439,0)
 ;;=3DTREATMENT^4^51
 ;;^UTILITY(U,$J,358.4,440,0)
 ;;=3DMISCELLANEOUS^7^51
 ;;^UTILITY(U,$J,358.4,441,0)
 ;;=3DIMMUNIZATIONS^6^51
 ;;^UTILITY(U,$J,358.4,442,0)
 ;;=3DCHEMO ADMINISTRATION^1^51
 ;;^UTILITY(U,$J,358.4,443,0)
 ;;=3DCHEMO DRUGS^2^51
 ;;^UTILITY(U,$J,358.4,444,0)
 ;;=3DOTHER DRUGS^3^51
 ;;^UTILITY(U,$J,358.4,445,0)
 ;;=3DNEW PATIENT^2^52
 ;;^UTILITY(U,$J,358.4,446,0)
 ;;=3DESTABLISHED PATIENT^1^52
 ;;^UTILITY(U,$J,358.4,447,0)
 ;;=3DCONSULTATIONS^3^52
 ;;^UTILITY(U,$J,358.4,448,0)
 ;;=3DINJECTION/ASPIRATION^2^53
 ;;^UTILITY(U,$J,358.4,449,0)
 ;;=3DFRACTURE DISLOCATION^3^53
 ;;^UTILITY(U,$J,358.4,450,0)
 ;;=3DAPPLICATION CAST^4^53
 ;;^UTILITY(U,$J,358.4,451,0)
 ;;=3DAPPLICATION SPLINTS^5^53
 ;;^UTILITY(U,$J,358.4,452,0)
 ;;=3DOTHER/REMOVAL/REVISION^6^53
 ;;^UTILITY(U,$J,358.4,453,0)
 ;;=3DFOLLOW-UP VISITS^1^53
 ;;^UTILITY(U,$J,358.4,454,0)
 ;;=3DSUPPLIES/SOFT GOODS^7^53
 ;;^UTILITY(U,$J,358.4,455,0)
 ;;=3DSUPPLIES/DRUGS^8^53
 ;;^UTILITY(U,$J,358.4,456,0)
 ;;=3DREPAIR/CLOSURE^9^53
 ;;^UTILITY(U,$J,358.4,457,0)
 ;;=3DNEW PATIENT^2^54
 ;;^UTILITY(U,$J,358.4,458,0)
 ;;=3DESTABLISHED PATIENT^1^54
 ;;^UTILITY(U,$J,358.4,459,0)
 ;;=3DCONSULTATIONS^3^54
 ;;^UTILITY(U,$J,358.4,460,0)
 ;;=3DFOOT/TOE^1^55
 ;;^UTILITY(U,$J,358.4,461,0)
 ;;=3DOTHER^3^55
 ;;^UTILITY(U,$J,358.4,462,0)
 ;;=3DPAIN^2^55
 ;;^UTILITY(U,$J,358.4,463,0)
 ;;=3DHAND/FINGER^2^56
 ;;^UTILITY(U,$J,358.4,464,0)
 ;;=3DWRIST^3^56
 ;;^UTILITY(U,$J,358.4,465,0)
 ;;=3DFOREARM^4^56
 ;;^UTILITY(U,$J,358.4,466,0)
 ;;=3DELBOW^5^56
 ;;^UTILITY(U,$J,358.4,467,0)
 ;;=3DHUMERUS^1^57
 ;;^UTILITY(U,$J,358.4,468,0)
 ;;=3DSHOULDER^2^57
 ;;^UTILITY(U,$J,358.4,469,0)
 ;;=3DSPINE/GENERAL^3^57
 ;;^UTILITY(U,$J,358.4,470,0)
 ;;=3DCERVICAL SPINE^4^57
 ;;^UTILITY(U,$J,358.4,471,0)
 ;;=3DTHORACIC^5^57
 ;;^UTILITY(U,$J,358.4,472,0)
 ;;=3DLUMBAR SPINE^6^57
 ;;^UTILITY(U,$J,358.4,473,0)
 ;;=3DSACRUM/COCCYX^7^57
 ;;^UTILITY(U,$J,358.4,474,0)
 ;;=3DPELVIS/HIP^8^57
 ;;^UTILITY(U,$J,358.4,475,0)
 ;;=3DFEMUR/THIGH^4^58
 ;;^UTILITY(U,$J,358.4,476,0)
 ;;=3DKNEE^5^58
 ;;^UTILITY(U,$J,358.4,477,0)
 ;;=3DTIBIA/FIBULA^6^58
 ;;^UTILITY(U,$J,358.4,478,0)
 ;;=3DANKLE^7^58
 ;;^UTILITY(U,$J,358.4,479,0)
 ;;=3DSECONDARY DX ONLY^3^59
 ;;^UTILITY(U,$J,358.4,480,0)
 ;;=3DFOLLOW-UP DIAGNOSIS^2^59
 ;;^UTILITY(U,$J,358.4,481,0)
 ;;=3DSUTURES/DRESSINGS^1^59
 ;;^UTILITY(U,$J,358.4,482,0)
 ;;=3DINCISION & DRAINAGE^3^60
 ;;^UTILITY(U,$J,358.4,483,0)
 ;;=3DDEBRIDEMENT^5^60
 ;;^UTILITY(U,$J,358.4,484,0)
 ;;=3DSHAVING EPIDERMAL/DERMAL LESIONS^6^60
 ;;^UTILITY(U,$J,358.4,485,0)
 ;;=3DNAILS^2^60
 ;;^UTILITY(U,$J,358.4,486,0)
 ;;=3DPARING OR CUTTING^4^60
 ;;^UTILITY(U,$J,358.4,487,0)
 ;;=3DCONSCIOUS SEDATION^8^60
 ;;^UTILITY(U,$J,358.4,488,0)
 ;;=3DDESTRUCTION, BENIGN OR PREMALIGANT^7^60
 ;;^UTILITY(U,$J,358.4,489,0)
 ;;=3DEXCISION-BENIGN LESION (EXCEPT SKIN TAG)^9^60
 ;;^UTILITY(U,$J,358.4,490,0)
 ;;=3DEXCISION-MALIGNANT LESIONS^10^60
 ;;^UTILITY(U,$J,358.4,491,0)
 ;;=3DREPAIR/CLOSURE^11^60
 ;;^UTILITY(U,$J,358.4,492,0)
 ;;=3DBURNS^12^60
 ;;^UTILITY(U,$J,358.4,493,0)
 ;;=3DOTHER SKIN PROCEDURES^13^60
 ;;^UTILITY(U,$J,358.4,494,0)
 ;;=3DINJECTIONS^15^60
 ;;^UTILITY(U,$J,358.4,495,0)
 ;;=3DINJECTION SUBSTANCE^16^60
 ;;^UTILITY(U,$J,358.4,496,0)
 ;;=3DREPAIR, REVISE and/or RECONSTRUCT^17^60
 ;;^UTILITY(U,$J,358.4,497,0)
 ;;=3DINCISION - FOOT & TOES^17^60
 ;;^UTILITY(U,$J,358.4,498,0)
 ;;=3DEXCISION - FOOT & TOES^18^60
 ;;^UTILITY(U,$J,358.4,499,0)
 ;;=3DOTHER PROCEDURES^19^60
 ;;^UTILITY(U,$J,358.4,500,0)
 ;;=3DOPEN OR CLOSED TREATMENT OF FRACTURES^20^60
 ;;^UTILITY(U,$J,358.4,501,0)
 ;;=3DARTHRODESIS^21^60
 ;;^UTILITY(U,$J,358.4,502,0)
 ;;=3DCASTS/SPLINTS/STRAPPING APPLICATION^23^60
 ;;^UTILITY(U,$J,358.4,503,0)
 ;;=3DREMOVAL/REPAIR OF CASTS^24^60
 ;;^UTILITY(U,$J,358.4,504,0)
 ;;=3DOTHER ORTHOTICS^25^60
 ;;^UTILITY(U,$J,358.4,505,0)
 ;;=3DSUPPLIES^26^60
 ;;^UTILITY(U,$J,358.4,506,0)
 ;;=3DREMOVAL^14^60
 ;;^UTILITY(U,$J,358.4,507,0)
 ;;=3DAMPUTATION^22^60
 ;;^UTILITY(U,$J,358.4,508,0)
 ;;=3DNEW PATIENT^2^61
 ;;^UTILITY(U,$J,358.4,509,0)
 ;;=3DESTABLISHED PATIENT^1^61
 ;;^UTILITY(U,$J,358.4,510,0)
 ;;=3DCONSULTATIONS^3^61
 ;;^UTILITY(U,$J,358.4,511,0)
 ;;=3DALPHA ORDER (A)^2^62
 ;;^UTILITY(U,$J,358.4,512,0)
 ;;=3DALPHA ORDER (B)^3^62
 ;;^UTILITY(U,$J,358.4,513,0)
 ;;=3DALPHA ORDER (C)^4^62
 ;;^UTILITY(U,$J,358.4,514,0)
 ;;=3DALPHA ORDER (D)^5^62
 ;;^UTILITY(U,$J,358.4,515,0)
 ;;=3DALPHA ORDER (E)^6^62
 ;;^UTILITY(U,$J,358.4,516,0)
 ;;=3DALPHA ORDER (F)^7^62
 ;;^UTILITY(U,$J,358.4,517,0)
 ;;=3DALPHA ORDER (G)^8^62
 ;;^UTILITY(U,$J,358.4,518,0)
 ;;=3DALPHA ORDER (H)^9^62
 ;;^UTILITY(U,$J,358.4,519,0)
 ;;=3DALPHA ORDER (I)^10^62
 ;;^UTILITY(U,$J,358.4,520,0)
 ;;=3DALPHA ORDER (K)^11^62
 ;;^UTILITY(U,$J,358.4,521,0)
 ;;=3DALPHA ORDER (L)^12^62
 ;;^UTILITY(U,$J,358.4,522,0)
 ;;=3DALPHA ORDER (M)^13^62
 ;;^UTILITY(U,$J,358.4,523,0)
 ;;=3DALPHA ORDER (N)^14^62
 ;;^UTILITY(U,$J,358.4,524,0)
 ;;=3DALPHA ORDER (O)^15^62
 ;;^UTILITY(U,$J,358.4,525,0)
 ;;=3DALPHA ORDER (P)^16^62
 ;;^UTILITY(U,$J,358.4,526,0)
 ;;=3DALPHA ORDER (R)^17^62
 ;;^UTILITY(U,$J,358.4,527,0)
 ;;=3DALPHA ORDER (S)^18^62
 ;;^UTILITY(U,$J,358.4,528,0)
 ;;=3DALPHA ORDER (T)^19^62
 ;;^UTILITY(U,$J,358.4,529,0)
 ;;=3DALPHA ORDER (U)^20^62
 ;;^UTILITY(U,$J,358.4,530,0)
 ;;=3DALPHA ORDER (V)^21^62
 ;;^UTILITY(U,$J,358.4,531,0)
 ;;=3DALPHA ORDER (X)^22^62
 ;;^UTILITY(U,$J,358.4,532,0)
 ;;=3DIMMUNIZATION^2^63
 ;;^UTILITY(U,$J,358.4,533,0)
 ;;=3DINJECTION^3^63
 ;;^UTILITY(U,$J,358.4,534,0)
 ;;=3DSKIN TEST^4^63
 ;;^UTILITY(U,$J,358.4,535,0)
 ;;=3DNURSING PROCEDURES^5^63
 ;;^UTILITY(U,$J,358.4,536,0)
 ;;=3DMINOR PROCEDURES^6^63
 ;;^UTILITY(U,$J,358.4,537,0)
 ;;=3DSPLINTS^7^63
 ;;^UTILITY(U,$J,358.4,538,0)
 ;;=3DNEW PATIENT^2^64
 ;;^UTILITY(U,$J,358.4,539,0)
 ;;=3DESTABLISHED PATIENT^1^64
 ;;^UTILITY(U,$J,358.4,540,0)
 ;;=3DCARDIOVASCULAR^1^65
 ;;^UTILITY(U,$J,358.4,541,0)
 ;;=3DENDOCRINE/METABOLIC^3^65
 ;;^UTILITY(U,$J,358.4,542,0)
 ;;=3DPULMONARY^20^65
 ;;^UTILITY(U,$J,358.4,543,0)
 ;;=3DEENT^4^65
 ;;^UTILITY(U,$J,358.4,544,0)
 ;;=3DMUSCULOSKELETAL^9^65
 ;;^UTILITY(U,$J,358.4,545,0)
 ;;=3DNEURO^15^65
 ;;^UTILITY(U,$J,358.4,546,0)
 ;;=3DMENTAL HEALTH^13^65
 ;;^UTILITY(U,$J,358.4,547,0)
 ;;=3DGASTROENTEROLOGY^5^65
 ;;^UTILITY(U,$J,358.4,548,0)
 ;;=3DGU / RENAL^6^65
 ;;^UTILITY(U,$J,358.4,549,0)
 ;;=3DWOMEN'S HEALTH^28^65
 ;;^UTILITY(U,$J,358.4,550,0)
 ;;=3DHEMATOLOGY/ONCOLOGY^7^65
